Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Rhythm Biosciences Ltd. ( (AU:RHY) ) has shared an update.
Rhythm Biosciences Ltd. announced a proposed issue of 333,333 ordinary fully paid securities, scheduled for September 18, 2025. This move is part of a placement or other type of issue, potentially enhancing the company’s capital structure and supporting its strategic initiatives in the biotechnology sector.
More about Rhythm Biosciences Ltd.
Rhythm Biosciences Ltd. operates in the biotechnology industry, focusing on the development of diagnostic technologies. The company primarily offers products aimed at improving early detection and treatment outcomes for various diseases, with a significant emphasis on cancer diagnostics.
Average Trading Volume: 806,698
Technical Sentiment Signal: Sell
Current Market Cap: A$27.98M
See more insights into RHY stock on TipRanks’ Stock Analysis page.